
|Articles|December 13, 2007
Trilostane: A new treatment option for dogs with hyperadrenocorticism (1:40)
Author(s)David S. Bruyette, DVM, DACVIM
"The advantage of trilostane seems to be a much higher safety profile than Lysodren with an equal efficacy rate."
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on dvm360
1
New World screwworm confirmed in United States, USDA announces
2
Dog rescued from landfill undergoes complex orthopedic surgery at UC Davis
3
Before they become veterinarians, they become loyal
4
FDA approves first generic ketoprofen injectable for fever control in cattle with BRD
5










